Latest Articles

Publication Date
Awareness gap linked to years-long diagnostic delays for endometriosis patients - b2bnews.co.nz

Awareness gap linked to years-long diagnostic delays for endometriosis patients b2bnews.co.nz

Published: June 18, 2026, 5:16 a.m.
The Role of Molecular Characterization in Precision Medicine in Endometriosis.

Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows in other parts of the body. It affects roughly 1 in 10 women of …

Published: June 18, 2026, midnight
Motivation to join and supportive activity within online health communities among patients with persistent pain: A survey-based examination.

Online Health Communities (OHCs) are key platforms for people seeking medical information and social support. Individuals with persistent pain often use these communities to better understand their condition, share experiences, …

Published: June 18, 2026, midnight
How femtech is helping fibromyalgia patients - FemTech World

How femtech is helping fibromyalgia patients FemTech World

Published: June 17, 2026, 11:26 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted

Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times

Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore

Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri

Published: June 17, 2026, 7:01 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Cision News

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Cision News

Published: June 17, 2026, 7 a.m.
Placenta Accreta Spectrum Risk in Endometriosis: A Retrospective Cohort Study with ART Subanalysis.

Background/Objectives: This study assessed whether endometriosis is associated with an increased risk of placenta accreta spectrum (PAS) disorders and investigated if assisted reproductive technology (ART) further increases the risk in …

Published: June 17, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!